ArticlePLOS global public health2026

QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial.

Gareth Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.